These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 871366)

  • 21. Dissociation between tumour resistance and delayed-type hypersensitivity to tumour-associated antigens in the mouse.
    Henderson DC; Parker D; Turk JL
    Immunology; 1980 Jan; 39(1):1-9. PubMed ID: 7380461
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Macrophages and lymphoid tissues in mice with concomitant tumour immunity.
    Nelson DS; Kearney R
    Br J Cancer; 1976 Sep; 34(3):221-6. PubMed ID: 973997
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumour metastasis in mice with reduced immune reactivity. IV. Restoration of relative resistance to metastasis formation in thymectomized sub-lethally irradiated mice by spleen cells.
    Suurküla M; Boeryd B
    Pathol Eur; 1975; 10(4):299-305. PubMed ID: 1208121
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibody response of mice to chemically induced tumors.
    Brown JP; Klitzman JM; Hellström I; Nowinski RC; Hellström KE
    Proc Natl Acad Sci U S A; 1978 Feb; 75(2):955-8. PubMed ID: 204940
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of transplanted methylcholanthrene induced fibrosarcomata and Corynebacterium parvum on the immune response of CBA and A-HeJ mice to thymus dependent and independent antigens.
    James K; Ghaffar A; Milne I
    Br J Cancer; 1974 Jan; 29(1):11-20. PubMed ID: 4820942
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Further studies on the effect of a transplanted methylcholanthrene-induced fibrosarcoma on humoral immunity in CBA mice.
    James K; Milne I; Warr G
    Clin Exp Immunol; 1974 Oct; 18(2):243-50. PubMed ID: 4468197
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cell-mediated suppression of tumor immunity has a non-specific component. I. Evidence from transplantation tests.
    Hellström KE; Hellström I
    Int J Cancer; 1981; 27(4):481-5. PubMed ID: 6168591
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vivo and in vitro studies of the influence of the immune status of C3Hf-Bu mice on the effectiveness of local irradiation of a methylcholanthrene-induced fibrosarcoma.
    Jurin M; Suit HD
    Cancer Res; 1972 Oct; 32(10):2201-11. PubMed ID: 5080765
    [No Abstract]   [Full Text] [Related]  

  • 29. Tumor-specific immunity in 3-methylcholanthrene-induced murine fibrosarcomas. I. In vivo demonstration of immunity with three preparations of soluble antigens.
    Brannen GE; Adams JS; Santos GW
    J Natl Cancer Inst; 1974 Jul; 53(1):165-75. PubMed ID: 4600504
    [No Abstract]   [Full Text] [Related]  

  • 30. Expression of alien H-2 specificities of a chemically induced BALB/c fibrosarcoma.
    Meschini A; Invernizzi G; Parmiami G
    Int J Cancer; 1977 Aug; 20(2):271-83. PubMed ID: 70414
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cellular basis for the immune response to methylcholanthrene-induced tumors in mice. Heterogeneity of effector cells.
    Kearney R; Basten A; Nelson DS
    Int J Cancer; 1975 Mar; 15(3):438-50. PubMed ID: 1079792
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transfer of immunity to tumour isografts by the systemic administration of xenogeneic "immune" RNA.
    Deckers PJ; Pilch YH
    Nat New Biol; 1971 Jun; 231(23):181-3. PubMed ID: 5281197
    [No Abstract]   [Full Text] [Related]  

  • 33. Effects of Corynebacterium granulosum on weight and histology of lymphoid organs, response to mitogens, skin allografts, and a syngeneic fibrosarcoma in mice.
    Milas L; Basic I; Kogelnik HD; Withers HR
    Cancer Res; 1975 Sep; 35(9):2365-74. PubMed ID: 807323
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Subcutaneous injection of spleen cells from mice bearing large methylcholanthrene-induced sarcoma enhances subcutaneous tumors and artificial pulmonary metastases].
    Tsuchiya K; Yamagishi H; Hamada H; Komichi H; Oka T; Tanaka T; Inaba S
    Nihon Geka Gakkai Zasshi; 1987 Jul; 88(7):826-31. PubMed ID: 2444868
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The immunospecificity of altered initial arrest patterns of circulating cancer cells in tumor-bearing mice.
    Weiss L; Glaves D
    Int J Cancer; 1976 Dec; 18(6):774-7. PubMed ID: 1036490
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immune response to chemically induced tumours: correlation of responding cell class with in vivo inhibition of tumour growth.
    Calderwood MB; Forbes JT; Smith RT
    Br J Cancer; 1981 Apr; 43(4):505-16. PubMed ID: 6972224
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effects of levamisole on methylcholanthrene-induced tumor. I. Its antitumor effect and immunological mechanism].
    Gomi K; Morimoto M; Nomoto K
    Gan To Kagaku Ryoho; 1982 Jul; 9(7):1262-8. PubMed ID: 7184454
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibody production by spleen cells of mice bearing MCA-induced tumours: search for suppressor cells.
    Yagello M; Lespinats G; Fridman WH
    Int J Cancer; 1978 Aug; 22(2):136-41. PubMed ID: 359487
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of carrageenan, PVP and tumour-bearer serum on immunity induced by excision or mitomycin C-treated tumour cells in mice.
    Kearney R; Wu RL; Orr F
    Br J Cancer; 1979 Jun; 39(6):648-58. PubMed ID: 444404
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes in spleen morphology and lymphoid cell activity during tumor progression.
    Yamagishi H; Pellis NR; Macek C; Kahan BD
    Eur J Cancer (1965); 1980 Nov; 16(11):1417-26. PubMed ID: 7227418
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.